The U.S. optic neuritis market is expected to reach USD 6.11 million by 2029 from USD 4.15 million in 2021, growing at a CAGR of 5.0% in the forecast period of 2029.
Industry Analysis
The growing prevalence of eye disorders in the region and the rise in the geriatric population has enhanced the demand of the market. The rising healthcare expenditure for better health services is also attributed to the growth of the market. The major market players are highly focused on product launches and approvals during this crucial period. In addition, the government and regulatory bodies are supporting market players by product approval due to the surging emergence.
Optic neuritis is characterized as a swelling or inflammation that occurs in the optic nerve. It is also commonly termed as optic papillitis and retro tubular neuritis. The optic nerves is a nerve fibres that has the capability of transmitting visual information from the eye to the brain. The inflammation usually leads to damage in the optic nerve and temporary vision loss in only one eye typically. Pediatric optic neuritis and adult optic neuritis and are two types which is based on the age group of patients diagnosed with optic neuritis. The common way to diagnose the optic neuritis is through a physical exam and medical history. The treatment becomes essential at an early stage due to the lifetime risk of losing human eye vision in this disorder. The most common symptoms associated with optic neuritis include pain with eye movement and dyschromatopsia or inability to see colors correctly. For instance, as per an article in the Journal of Neurology stated that the annual incidence of optic neuritis in the U.S. is found to be around 5/1,000,000, with an estimated prevalence of 115/1,000,000.
The U.S. Optic Neuritis Market Scope
The U.S. optic neuritis market is segmented into treatment, diagnosis, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Treatment
- Corticosteroids
- IV Immunoglobulin
- Supplements
- Others
Diagnosis
- MRI Scan
- Lumbar Puncture
- Ocular Coherence Tomography
- Blood Test
- Others
Route of Administration
- Parenteral
- Oral
End User
- Hospitals
- Clinics
- Academic Research Institutes
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-optic-neuritis-market
Optic Neuritis Market Regional Analysis/Insights
The optic neuritis market is analyzed, and market size insights and trends are provided by country, treatment, diagnosis, route of administration, end user, and distribution channel, as referenced above.
The U.S. dominates the optic neuritis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to implementing awareness programs regarding the diagnosis and treatments of optic neuritis, and research and development in the drugs for optic neuritis in the U.S. region further improves this market growth.
Competitive Landscape and Optic Neuritis Market Share Analysis
The optic neuritis market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the optic neuritis market.
Some of the major players operating in the optic neuritis market are
- AbbVie Inc.,
- Bausch Lomb Incorporated,
- Boehringer Ingelheim International GmbH,
- Novartis AG,
- Merck Co., Inc.,
- Hikma Pharmaceuticals PLC,
- Fresenius Kabi USA,
- Teva Pharmaceuticals Industries Ltd.,
- GSK plc,
- Pfizer,
- Akorn Operating Company LLC,
- AdvaCare Pharma,
- Bristol- Myers Squibb Company,
- Jubilant Cadista Pharmaceuticals Inc.,
- Amneal Pharmaceuticals LLC.
- Viatris Inc.,
- Novitium Pharma,
- Among others.
Get Full Access of reports @ https://www.databridgemarketresearch.com/reports/us-optic-neuritis-market
MAJOR TOC OF THE REPORT
- Chapter One: Introduction
- Chapter Two: Market Segmentation
- Chapter Three: Market Overview
- Chapter Four: Executive Summary
- Chapter Five: Premium Insights
- Chapter Six: U.S. Optic Neuritis Market by Product Procedure type
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=us-optic-neuritis-market
Browse Related Reports @
https://www.databridgemarketresearch.com/reports/global-digitally-printed-wallpaper-market
https://www.databridgemarketresearch.com/reports/global-winter-wear-market
https://www.databridgemarketresearch.com/reports/global-edible-films-coatings-market
https://www.databridgemarketresearch.com/reports/global-milk-protein-hydrolysate-market
https://www.databridgemarketresearch.com/reports/global-biometrics-as-a-service-market
https://www.databridgemarketresearch.com/reports/global-iot-monetization-market
About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
